title: ARC, an apoptosis suppressor limited to terminally differentiated cells, is induced in human breast cancer and confers chemo- and radiation-resistance.
authors.forename: I
authors.initials: I
authors.lastname: Mercier
authors.forename: M
authors.initials: M
authors.lastname: Vuolo
authors.forename: R
authors.initials: R
authors.lastname: Madan
authors.forename: X
authors.initials: X
authors.lastname: Xue
authors.forename: A J
authors.initials: AJ
authors.lastname: Levalley
authors.forename: A W
authors.initials: AW
authors.lastname: Ashton
authors.forename: J-F
authors.initials: JF
authors.lastname: Jasmin
authors.forename: M T
authors.initials: MT
authors.lastname: Czaja
authors.forename: E Y
authors.initials: EY
authors.lastname: Lin
authors.forename: R C
authors.initials: RC
authors.lastname: Armstrong
authors.forename: J W
authors.initials: JW
authors.lastname: Pollard
authors.forename: R N
authors.initials: RN
authors.lastname: Kitsis
mesh_terms: D051017:Apoptosis Regulatory Proteins; D001943:Breast Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology / Q000532:radiotherapy; D002454:Cell Differentiation; D002460:Cell Line; D004317:Doxorubicin / Q000494:pharmacology; D019008:Drug Resistance, Neoplasm; D006801:Humans; D009124:Muscle Proteins / Q000378:metabolism*; D011836:Radiation Tolerance
chemical_list: D051017:Apoptosis Regulatory Proteins; D009124:Muscle Proteins; C112246:NOL3 protein, human; D004317:Doxorubicin